These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31881876)

  • 1. The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: a modelled analysis.
    Berrigan P; Andrew G; Reynolds JN; Zwicker JD
    BMC Public Health; 2019 Dec; 19(1):1746. PubMed ID: 31881876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis.
    Hopkins RB; Paradis J; Roshankar T; Bowen J; Tarride JE; Blackhouse G; Lim M; O'Reilly D; Goeree R; Longo CJ
    J Stud Alcohol Drugs; 2008 Jul; 69(4):510-9. PubMed ID: 18612566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of the Neurobehavioral Screening Tool to identifying fetal alcohol spectrum disorders in children at high risk of prenatal alcohol exposure and neurobehavioral deficits.
    Ronen D; Senecky Y; Chodick G; Ganelin-Cohen E
    Early Hum Dev; 2022 Jul; 170():105608. PubMed ID: 35738133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the neurobehavioral screening tool in children with fetal alcohol spectrum disorders (FASD).
    LaFrance MA; McLachlan K; Nash K; Andrew G; Loock C; Oberlander TF; Koren G; Rasmussen C
    J Popul Ther Clin Pharmacol; 2014; 21(2):e197-210. PubMed ID: 24897061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal alcohol spectrum disorder and the neurobehavioural screening tool: evaluating the effect of maternal depression.
    Haynes K; Nulman I; Koren G
    J Popul Ther Clin Pharmacol; 2014; 21(3):e387-94. PubMed ID: 25353623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the neurobehavioral phenotype of fetal alcohol spectrum disorder in young children.
    Breiner P; Nulman I; Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(3):e334-9. PubMed ID: 24163185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Canadian screening tools for fetal alcohol spectrum disorder.
    Goh YI; Chudley AE; Clarren SK; Koren G; Orrbine E; Rosales T; Rosenbaum C;
    Can J Clin Pharmacol; 2008; 15(2):e344-66. PubMed ID: 18840921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of fetal alcohol spectrum disorder diagnosis in Canada.
    Popova S; Lange S; Burd L; Chudley AE; Clarren SK; Rehm J
    PLoS One; 2013; 8(4):e60434. PubMed ID: 23593216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying fetal alcohol spectrum disorder among South African children at aged 1 and 5 years.
    Wynn A; Rotheram-Borus MJ; Davis E; le Roux I; Almirol E; O'Connor M; Tomlinson M
    Drug Alcohol Depend; 2020 Dec; 217():108266. PubMed ID: 32956976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meconium testing for fatty acid ethyl esters: a 2011 status report.
    MacLeod S; Koren G
    J Popul Ther Clin Pharmacol; 2011; 18(3):e500-2. PubMed ID: 22987672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based prevalence of fetal alcohol spectrum disorder in Canada.
    Popova S; Lange S; Poznyak V; Chudley AE; Shield KD; Reynolds JN; Murray M; Rehm J
    BMC Public Health; 2019 Jun; 19(1):845. PubMed ID: 31253131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the behavioural phenotype in Fetal Alcohol Spectrum Disorder: sensitivity, specificity and screening potential.
    Nash K; Rovet J; Greenbaum R; Fantus E; Nulman I; Koren G
    Arch Womens Ment Health; 2006 Jul; 9(4):181-6. PubMed ID: 16673042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of benefits of a universal screen for maternal alcohol use during pregnancy.
    Gifford AE; Farkas KJ; Jackson LW; Molteno CD; Jacobson JL; Jacobson SW; Bearer CF
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):838-46. PubMed ID: 20890939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening approaches for identifying fetal alcohol spectrum disorder in children, adolescents, and adults: A systematic review.
    Grubb M; Golden A; Withers A; Vellone D; Young A; McLachlan K
    Alcohol Clin Exp Res; 2021 Aug; 45(8):1527-1547. PubMed ID: 34453340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of health services utilization of people with fetal alcohol spectrum disorder by sex and age group in Alberta, Canada.
    Thanh NX; Jonsson E
    J Popul Ther Clin Pharmacol; 2014; 21(3):e421-30. PubMed ID: 25658807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Canadian prenatal record forms integrate evidence-based guidelines for the diagnosis of a FASD?
    Premji SS; Semenic S
    Can J Public Health; 2009; 100(4):274-80. PubMed ID: 19722340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal alcohol spectrum disorders screening tools: A systematic review.
    Lim YH; Watkins RE; Jones H; Kippin NR; Finlay-Jones A
    Res Dev Disabil; 2022 Mar; 122():104168. PubMed ID: 34996007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal alcohol spectrum disorder: neurodevelopmentally and behaviorally indistinguishable from other neurodevelopmental disorders.
    Lange S; Shield K; Rehm J; Anagnostou E; Popova S
    BMC Psychiatry; 2019 Oct; 19(1):322. PubMed ID: 31660907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian clinical capacity for fetal alcohol spectrum disorder assessment, diagnosis, disclosure and support to children and adolescents: a cross-sectional study.
    Dugas EN; Poirier M; Basque D; Bouhamdani N; LeBreton L; Leblanc N
    BMJ Open; 2022 Aug; 12(8):e065005. PubMed ID: 36041771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal alcohol spectrum disorder: a systematic review of the cost of and savings from prevention in the United States and Canada.
    Greenmyer JR; Popova S; Klug MG; Burd L
    Addiction; 2020 Mar; 115(3):409-417. PubMed ID: 31628757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.